VolitionRx
Henderson, Nevada, United States · Biotechnology, Genetics, Health Care
VolitionRx Limited is a multi-national epigenetics company dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. The company is focused on advancing the science of epigenetics and developing simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of dis
Key facts
- Headquarters
- Henderson, Nevada, United States
- Employees
- 86
- Industries
- Biotechnology, Genetics, Health Care
- Status
- Public (VNRX)
- Website
- volitionrx.com
- Company page
Recent activity at VolitionRx
- : VolitionRx Secures Funding Through Convertible Promissory Note
- : VOLITIONRX LTD
- : VolitionRx and Hologic Enter Co-Marketing Agreement for Nu.Q® Discover Services.
- : VOLITIONRX LTD
- : Volition Signs Automated Cancer Test Agreement with Fujifilm Vet Systems
- : VolitionRx Limited Launches High Throughput Synthetic Sepsis Method to Aid Therapeutic Development for NETs-Related Diseases.
- : VOLITIONRX LTD
- : VolitionRx Limited Appoints Dr Andrew Retter as Chief Medical Officer
- : Volitionrx Secures Approximately $5.5 Million In Belgium Regional Government Financing From Wallonie Entreprendre
- : VOLITIONRX LTD
VolitionRx funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2026 | Convertible Note | $2.4M |
| May 2025 | Venture | $16.3M |
| Mar 2024 | Pre-Seed | $100K |
| Dec 2023 | Funding Round | $5.5M |
| Aug 2018 | Venture | $24.0M |
Leadership
- Edward Futcher, Director
- Habib Skaff, Director
- Alan Colman, Director
- Guy Innes, Director
- Martin Faulkes, Director
- Cameron Reynolds, Executive Officer, Director
- Terig Hughes, Chief Financial Officer
- Louise Batchelor, Group Chief Marketing & Communications Officer
- PHILLIP BARNES, Director
Verified email and direct lines for VolitionRx’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
VolitionRx in the news
- VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets - Yahoo Finance (Aug 26, 2026)
- VolitionRx Limited Executes a Contract for Clinical Trial Program in Lung Cancer - NAI500 (May 08, 2019)
- VolitionRX: Q3 Earnings Snapshot - KVUE (Nov 12, 2026)
- VolitionRx Announces Pricing of $4.6 Million Public Offering - Yahoo Finance (Jun 07, 2026)
- VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats - PR Newswire (May 06, 2026)
- VNRX Stock Price and Chart — AMEX:VNRX - TradingView (Jul 21, 2017)
- VolitionRx Limited (VNRX): 7 Best Rated Penny Stocks to Buy According to Wall Street Analysts - Yahoo Finance (May 24, 2026)
- VolitionRx (NYSEAM:VNRX) - Stock Analysis - Simply Wall St (Dec 02, 2017)
Companies similar to VolitionRx
- Gaomei Gene · Biotechnology, Genetics, Health Care, Health Diagnostics, Therapeutics
- GenoME Diagnostics · Biotechnology, Genetics, Health Care, Health Diagnostics, Therapeutics
- Passage Bio · Biotechnology, Genetics, Health Care, Therapeutics
- Pathos AI · Biotechnology, Health Care, Health Diagnostics, Therapeutics
- Predicine · Biotechnology, Health Care, Health Diagnostics, Therapeutics
About VolitionRx: questions and answers
What does VolitionRx do?
VolitionRx Limited is a multi-national epigenetics company dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. The company is focused on advancing the science of epigenetics and developing simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of dis
Where is VolitionRx headquartered?
VolitionRx is headquartered in Henderson, Nevada, United States.
How many employees does VolitionRx have?
VolitionRx has about 86 employees.
Has VolitionRx raised funding?
Yes. Fundz has recorded 5 funding events for VolitionRx. The most recent, Convertible Note of $2.4M, was in Oct 2026.
What is the latest news on VolitionRx?
On Oct 27, 2026, VolitionRx Secures Funding Through Convertible Promissory Note
Is VolitionRx a public company?
Yes. VolitionRx is publicly traded under the ticker VNRX.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy